代谢工程
大肠杆菌
蛋白质工程
生物化学
酶
化学
基质(水族馆)
生物合成
代谢途径
底物特异性
表面工程
催化作用
蛋白质生物合成
生物
细菌
新陈代谢
大肠杆菌蛋白质类
作者
Nan-Kai Wang,Song Yue,Jin‐Ping Chen,Chang Su,Zhen‐Ming Lu,Jin‐Song Gong,Wei E. Huang,Zhenghong Xu,Jin‐Song Shi
标识
DOI:10.1038/s41467-026-77406-2
摘要
N-Acetylneuraminic acid (NeuAc) is a sialic acid valued in pharmaceuticals and infant nutrition, and microbial synthesis offers a scalable route once the pathway’s catalytic bottlenecks are relieved. We combine deep learning with metabolic engineering to build a high-titer NeuAc-producing E.coli strain. Modular pathway engineering reaches 1.25 g L−1 and pinpoints N-acetylglucosamine 2-epimerase (AGE) as the rate-limiting step. We develop DLCatalysis, a deep learning framework that predicts kcat Km−1 directly from protein sequence and substrate, and use it to mine AGEBf that lifts the titer to 6.84 g L−1. DLCatalysis-guided redesign of AGEBf and NeuBNm raises NeuAc to 9.27 g L⁻¹, and identifying and deleting exuT, a previously unannotated NeuAc transporter, blocks product reuptake. In 5-L fed-batch fermentation the optimized strain produces 85.5 g L−1, showing that AI-guided enzyme discovery can resolve the bottlenecks that have limited microbial NeuAc production. N-Acetylneuraminic acid (NeuAc) is a valuable pharmaceutical. Here the authors develop DLCatalysis, a deep learning framework that predicts kinetics from protein sequence and substrate, and use DLCatalysis to mine enzymes for NeuAc production in E. coli.
科研通智能强力驱动
Strongly Powered by AbleSci AI